kainic acid has been researched along with Cognition Disorders in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (8.82) | 18.2507 |
2000's | 8 (23.53) | 29.6817 |
2010's | 23 (67.65) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tang, R; Tang, X; Yang, X; Yu, H | 1 |
Butler, CR; Guilmette, E; Pauletti, A; Piro, JR; Porcu, L; Rizzi, M; Salamone, A; Samad, TA; Sheehan, MJ; Terrone, G; Vezzani, A; Villa, BR | 1 |
Gu, Y; Han, Z; Jiang, Z; Lin, Z; Lu, D; Ma, W; Meng, Y; Na, M; Song, Y; Tang, C; Wang, H; Wang, Y; Wu, H | 1 |
Chen, W; He, Q; Hu, Y; Jiang, L; Man, S; Wu, L | 1 |
Barco, A; Del Blanco, B; Delgado-Garcia, JM; Gruart, A; Llinares, M; Medrano-Fernández, A; Olivares, R; Sánchez-Campusano, R | 1 |
Cheng, W; Hu, B; Li, MQ; Lu, J; Wu, DM; Zhang, YQ; Zhang, ZF; Zheng, YL | 2 |
Fahim, E; Friedman, LK; Halbsgut, LR; Hong, H; Kapoor, K | 1 |
Bian, YJ; Xie, QM; Xu, CJ; Xu, XJ; Zeng, LH; Zhang, HD; Zhang, RH | 1 |
Bartolomei, F; Becker, C; Benoliel, JJ; Bernard, C; Bouvier, E; Camus, F; Claverie, D; Ghestem, A; Siyoucef, S | 1 |
Agostinho, P; Augusto, E; Boison, D; Chen, JF; Cunha, RA; Matos, M; Shen, HY; Wang, Y; Wang, YT; Wei, CJ | 1 |
Ge, H; Guo, M; Hou, X; Jiang, Z; LaChaud, G; Lin, Z; Liu, L; Long, Y; Mu, L; Park, SH; Pu, S; Shen, H; Shen, J; Shi, C; Song, Y; Sun, J; Wang, H; Wang, X; Xie, C; Yao, L; Zarringhalam, A; Zhu, M | 1 |
Morales, T; Reyes-Mendoza, J | 1 |
Liu, T; Mu, X; Sun, X; Xiao, T; Zhao, C; Zhao, M; Zhou, Z; Zhu, G | 1 |
Carey, AN; Galli, RL; Ingram, DK; Joseph, JA; Lau, FC; Shukitt-Hale, B; Spangler, EL | 1 |
Agrawal, AK; Ansari, RW; Khanna, VK; Seth, K; Srivastava, N | 1 |
Branshaw, S; Brown-Borg, HM; Haselton, J; Rakoczy, S; Sharma, S | 1 |
Bellaver, B; Bogo, MR; Bonan, CD; Casali, E; Cognato, GP; Savio, LE; Sévigny, J; Souza, DO; Vuaden, FC | 1 |
Arya, DS; Bhatia, J; Chaudhry, U; Golechha, M; Saluja, D | 1 |
Kumar, A; Pahwa, D; Prakash, A | 1 |
Joo, SS; Kang, H; Kim, SU; Kim, TK; Kim, YB; Lee, HJ; Lee, SH; Lim, I; Matsuo, A; Park, D; Tooyama, I | 1 |
Cheng, W; Hu, B; Lu, J; Wu, DM; Zhang, ZF; Zheng, YL | 1 |
Kumar, A; Mishra, J; Pahwa, D; Prakash, A | 1 |
Antonucci, F; Bozzi, Y; Braida, D; Caleo, M; Clerici, M; Corradini, I; De Astis, S; Donzelli, A; Frassoni, C; Inverardi, F; Lipp, HP; Loos, M; Martucci, R; Matteoli, M; Pattini, L; Sala, M; Verderio, C; Welzl, H; Wolfer, D | 1 |
Brandt, C; Löscher, W; Rattka, M | 1 |
Arkhipov, VI; Shevchenko, NA | 1 |
Qin, YH; Song, LH; Wang, L; Zhang, HS | 1 |
Antonucci, F; Bozzi, Y; Caleo, M; Costantin, L; Funicello, M; Gobbi, M; Maffei, L; Mennini, T; Montecucco, C; Richichi, C; Rossetto, O; Vezzani, A; Viegi, A | 1 |
Bluthé, RM; Dantzer, R; Frenois, F; Kelley, KW | 1 |
Potera, C | 1 |
Agrawal, AK; Khanna, VK; Seth, K; Srivastava, N | 1 |
Holmes, GL; Liu, Z | 1 |
Bardgett, ME; Csernansky, CA; Csernansky, JG; Kogelman, L; Montgomery, EM | 1 |
Qiao, M; Zhang, S | 1 |
34 other study(ies) available for kainic acid and Cognition Disorders
Article | Year |
---|---|
Effects of spontaneous recurrent seizures on cognitive function via modulation of SNAREs expression.
Topics: Animals; Anticonvulsants; Cognition Disorders; Disease Models, Animal; Escape Reaction; Excitatory Amino Acid Agonists; Gene Expression Regulation; Hippocampus; Kainic Acid; Locomotion; Male; Maze Learning; Rats; Rats, Sprague-Dawley; Seizures; SNARE Proteins; Synapses; Synaptosomal-Associated Protein 25; Synaptotagmin I; Valproic Acid; Vesicle-Associated Membrane Protein 2 | 2018 |
Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet.
Topics: Animals; Brain; Brain Waves; Carbamates; Cognition Disorders; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistant Epilepsy; Electroencephalography; Excitatory Amino Acid Agonists; Fluoresceins; Kainic Acid; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monoacylglycerol Lipases; Neurons; Piperidines; Random Allocation; Receptor, Cannabinoid, CB1; Recognition, Psychology; Status Epilepticus; Sulfonamides; Time Factors | 2018 |
Targeting of microRNA-21-5p protects against seizure damage in a kainic acid-induced status epilepticus model via PTEN-mTOR.
Topics: Animals; Antagomirs; Anticonvulsants; Cognition Disorders; Disease Models, Animal; Excitatory Amino Acid Agonists; Gene Expression Regulation; Hippocampus; Injections, Intraventricular; Kainic Acid; Male; Maze Learning; MicroRNAs; PTEN Phosphohydrolase; Rats; Rats, Wistar; Statistics, Nonparametric; Status Epilepticus; Time Factors; TOR Serine-Threonine Kinases | 2018 |
Curcumin Reduces Neuronal Loss and Inhibits the NLRP3 Inflammasome Activation in an Epileptic Rat Model.
Topics: Animals; Anti-Inflammatory Agents; Cognition Disorders; Curcumin; Disease Models, Animal; Epilepsy; Excitatory Amino Acid Agonists; Female; Hippocampus; Inflammation; Interleukin-1beta; Kainic Acid; Male; Maze Learning; Neurons; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley | 2018 |
The Epigenetic Factor CBP Is Required for the Differentiation and Function of Medial Ganglionic Eminence-Derived Interneurons.
Topics: Action Potentials; Animals; Anxiety; Behavior, Animal; Cell Differentiation; Chromosome Mapping; Cognition Disorders; Epigenesis, Genetic; Epilepsy; Female; Hippocampus; Interneurons; Kainic Acid; Learning; Male; Median Eminence; Membrane Proteins; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Parvalbumins; Phosphoproteins; Somatostatin; Thyroid Nuclear Factor 1 | 2019 |
Ursolic acid improves domoic acid-induced cognitive deficits in mice.
Topics: Animals; Animals, Genetically Modified; Cognition Disorders; Cyclooxygenase Inhibitors; Dependovirus; Fluorescent Antibody Technique; Forkhead Box Protein O1; Forkhead Transcription Factors; Genetic Vectors; Hippocampus; Kainic Acid; Male; Maze Learning; Mice; Mice, Inbred ICR; Mitochondrial Diseases; Neuromuscular Depolarizing Agents; Oncogene Protein v-akt; Oxidative Stress; Phosphatidylinositol 3-Kinases; Psychomotor Performance; Signal Transduction; Triterpenes; Ursolic Acid | 2013 |
Certain secondary antiepileptic drugs can rescue hippocampal injury following a critical growth period despite poor anticonvulsant activity and cognitive deficits.
Topics: Age Factors; Animals; Animals, Newborn; Anticonvulsants; Body Weight; Brain Injuries; Cell Count; Cognition Disorders; Disease Models, Animal; Excitatory Amino Acid Agonists; Female; Hippocampus; Humans; Kainic Acid; Male; Maze Learning; Rats; Rats, Sprague-Dawley; Seizures; Treatment Outcome | 2013 |
Neuroprotective effects of flavonoids extracted from licorice on kainate-induced seizure in mice through their antioxidant properties.
Topics: Animals; Antioxidants; Cognition Disorders; Flavonoids; Glycyrrhiza; Kainic Acid; Male; Malondialdehyde; Mice; Mice, Inbred ICR; Neuroprotective Agents; Oxidative Stress; Status Epilepticus; Superoxide Dismutase | 2013 |
Predicting and treating stress-induced vulnerability to epilepsy and depression.
Topics: Allostasis; Animals; Brain-Derived Neurotrophic Factor; Cognition Disorders; Depression; Disease Models, Animal; Epilepsy; Excitatory Amino Acid Agonists; Flavones; Hypothalamo-Hypophyseal System; Kainic Acid; Male; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Social Environment; Status Epilepticus; Stress, Psychological | 2015 |
Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia.
Topics: Animals; Astrocytes; Cognition Disorders; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glutamic Acid; Homeostasis; Kainic Acid; Locomotion; Mice; Mice, Inbred C57BL; Mice, Transgenic; Psychomotor Disorders; Pyrimidines; Receptor, Adenosine A2A; Receptors, N-Methyl-D-Aspartate; Synaptosomes; Time Factors; Triazoles | 2015 |
Protection against cognitive impairment and modification of epileptogenesis with curcumin in a post-status epilepticus model of temporal lobe epilepsy.
Topics: Animals; Astrocytes; Cognition Disorders; Curcumin; Disease Models, Animal; Encephalitis; Epilepsy, Temporal Lobe; Hippocampus; Interleukin-1beta; Kainic Acid; Male; Rats; Rats, Wistar; Status Epilepticus; Tumor Necrosis Factor-alpha | 2015 |
Post-treatment with prolactin protects hippocampal CA1 neurons of the ovariectomized female rat against kainic acid-induced neurodegeneration.
Topics: Animals; Antigens, Nuclear; Astrocytes; CA1 Region, Hippocampal; Cognition Disorders; Disease Models, Animal; Female; Gliosis; Kainic Acid; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurogenesis; Neurons; Neuroprotective Agents; Ovariectomy; Prolactin; Random Allocation; Rats; Time Factors | 2016 |
CXCR4 antagonist AMD3100 reverses the neurogenesis promoted by enriched environment and suppresses long-term seizure activity in adult rats of temporal lobe epilepsy.
Topics: Animals; Anticonvulsants; Benzylamines; Chemokine CXCL12; Cognition Disorders; Cyclams; Disease Models, Animal; Epilepsy, Temporal Lobe; Heterocyclic Compounds; Hippocampus; Housing, Animal; Kainic Acid; Male; Neurogenesis; Neurons; Random Allocation; Rats, Wistar; Receptors, CXCR4; Seizures | 2017 |
Blueberry polyphenols attenuate kainic acid-induced decrements in cognition and alter inflammatory gene expression in rat hippocampus.
Topics: Animals; Blueberry Plants; Cognition Disorders; Diet; Flavonoids; Fruit; Gene Expression; Hippocampus; Inflammation; Insulin-Like Growth Factor I; Interleukin-1beta; Kainic Acid; Male; Maze Learning; NF-kappa B; Phenols; Phytotherapy; Plant Extracts; Polyphenols; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 2008 |
Long-term functional restoration by neural progenitor cell transplantation in rat model of cognitive dysfunction: co-transplantation with olfactory ensheathing cells for neurotrophic factor support.
Topics: Acetylcholine; Animals; Cells, Cultured; Coculture Techniques; Cognition Disorders; Disease Models, Animal; Female; Hippocampus; Kainic Acid; Male; Nerve Growth Factors; Nerve Regeneration; Neuroglia; Neurotoxins; Olfactory Bulb; Rats; Rats, Wistar; Recovery of Function; Stem Cell Transplantation; Stem Cells; Treatment Outcome | 2009 |
Spatial memory is enhanced in long-living Ames dwarf mice and maintained following kainic acid induced neurodegeneration.
Topics: Animals; Cognition; Cognition Disorders; Female; Gene Expression; Hippocampus; Insulin-Like Growth Factor I; Kainic Acid; Longevity; Male; Maze Learning; Memory; Mice; Mice, Mutant Strains; Neurodegenerative Diseases | 2010 |
Nucleoside triphosphate diphosphohydrolases role in the pathophysiology of cognitive impairment induced by seizure in early age.
Topics: Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Blotting, Western; Chromatography, High Pressure Liquid; Cognition Disorders; Convulsants; Gene Expression; Gene Expression Profiling; Hippocampus; Kainic Acid; Male; Maze Learning; Nucleoside-Triphosphatase; Pyrophosphatases; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Seizures | 2011 |
Naringin protects against kainic acid-induced status epilepticus in rats: evidence for an antioxidant, anti-inflammatory and neuroprotective intervention.
Topics: Animals; Anti-Inflammatory Agents; Anticonvulsants; Antioxidants; Avoidance Learning; Citrus; Cognition Disorders; Dose-Response Relationship, Drug; Flavanones; Glutathione; Kainic Acid; Male; Malondialdehyde; Neuroprotective Agents; Oxidative Stress; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Reaction Time; Status Epilepticus; Tumor Necrosis Factor-alpha | 2011 |
Galantamine potentiates the protective effect of rofecoxib and caffeic acid against intrahippocampal Kainic acid-induced cognitive dysfunction in rat.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Brain; Caffeic Acids; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Galantamine; Glutathione; Hippocampus; Kainic Acid; Lactones; Lipid Peroxidation; Maze Learning; Mitochondria; Motor Activity; NADH Dehydrogenase; Nitrites; Nootropic Agents; Rats; Rats, Wistar; Succinate Dehydrogenase; Sulfones; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2011 |
Human neural stem cells overexpressing choline acetyltransferase restore cognitive function of kainic acid-induced learning and memory deficit animals.
Topics: Acetylcholine; Alzheimer Disease; Animals; Astrocytes; CA3 Region, Hippocampal; Choline O-Acetyltransferase; Cognition Disorders; Disease Models, Animal; Humans; Kainic Acid; Learning; Male; Memory Disorders; Neural Stem Cells; Neurogenesis; Rats; Rats, Sprague-Dawley; Stem Cell Transplantation | 2012 |
Purple sweet potato color attenuates domoic acid-induced cognitive deficits by promoting estrogen receptor-α-mediated mitochondrial biogenesis signaling in mice.
Topics: Animals; Anthocyanins; Apoptosis; Catalase; Cognition Disorders; Endoplasmic Reticulum Stress; Estrogen Receptor alpha; Hippocampus; Ipomoea batatas; Kainic Acid; Male; Maze Learning; Mice; Mice, Inbred ICR; Mitochondria; NADPH Oxidases; Neurodegenerative Diseases; Neuroprotective Agents; Nuclear Respiratory Factor 1; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Plant Extracts; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Superoxide Dismutase-1; Trans-Activators; Transcription Factors; Up-Regulation | 2012 |
Small interfering RNA-mediated knockdown of protein kinase C zeta attenuates domoic acid-induced cognitive deficits in mice.
Topics: Animals; Base Sequence; Behavior, Animal; Cognition Disorders; DNA Primers; Gene Knockdown Techniques; Kainic Acid; Male; Mice; Mice, Inbred ICR; Protein Kinase C; RNA, Small Interfering | 2012 |
Montelukast potentiates the protective effect of rofecoxib against kainic acid-induced cognitive dysfunction in rats.
Topics: Acetates; Acetylcholinesterase; Animals; Antioxidants; Caffeic Acids; Cognition Disorders; Cyclooxygenase 2 Inhibitors; Cyclopropanes; Drug Synergism; Glutathione; Hippocampus; Kainic Acid; Lactones; Leukotriene Antagonists; Lipoxygenase Inhibitors; Maze Learning; Memory; Motor Activity; Neuroprotective Agents; Neurotoxins; Oxidation-Reduction; Oxidative Stress; Quinolines; Rats; Rats, Wistar; Sulfides; Sulfones; Tumor Necrosis Factor-alpha | 2012 |
Epileptiform activity and cognitive deficits in SNAP-25(+/-) mice are normalized by antiepileptic drugs.
Topics: Animals; Anticonvulsants; Association Learning; Brain; Carbamazepine; Cognition Disorders; Epilepsy; Ethosuximide; Hyperkinesis; Kainic Acid; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Nimodipine; Seizures; Synaptosomal-Associated Protein 25; Valproic Acid | 2014 |
The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats.
Topics: Animals; Anticonvulsants; Cognition Disorders; Disease Models, Animal; Epilepsy, Temporal Lobe; Female; Hippocampus; Hyperkinesis; Kainic Acid; Phenobarbital; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2013 |
Extinction of operant behavior as the test for cognitive disorders induced with kainic acid.
Topics: Animals; Anticonvulsants; Cognition Disorders; Conditioning, Operant; Extinction, Psychological; Kainic Acid; Male; Rats; Rats, Wistar; Valproic Acid | 2002 |
Lead can inhibit NMDA-, K(+)-, QA/KA-induced increases in intracellular free Ca2+ in cultured rat hippocampal neurons.
Topics: Animals; Calcium; Cognition Disorders; Disease Models, Animal; Hippocampus; Kainic Acid; Lead; Learning Disabilities; Microscopy, Confocal; N-Methylaspartate; Neurons; Potassium; Quisqualic Acid; Rats; Rats, Wistar | 2002 |
Antiepileptic effects of botulinum neurotoxin E.
Topics: Animals; Anticonvulsants; Botulinum Toxins; Cell Death; Cognition Disorders; Convulsants; Drug Evaluation, Preclinical; Electric Stimulation; Electroencephalography; Epilepsies, Partial; Epilepsy, Generalized; Glutamic Acid; Hippocampus; Injections, Intralesional; Kainic Acid; Kindling, Neurologic; Maze Learning; Membrane Proteins; Nerve Tissue Proteins; Pyramidal Cells; Random Allocation; Rats; Rats, Long-Evans; Stereotaxic Techniques; Synaptosomal-Associated Protein 25 | 2005 |
Pentoxifylline and insulin-like growth factor-I (IGF-I) abrogate kainic acid-induced cognitive impairment in mice.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cognition Disorders; Discrimination Learning; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fluoresceins; Free Radical Scavengers; Hippocampus; Insulin-Like Growth Factor Binding Protein 1; Kainic Acid; Male; Mice; Mice, Inbred ICR; Motor Activity; Nerve Degeneration; Neurons; Organic Chemicals; Pentoxifylline | 2005 |
Marine toxin hinders cognitive development.
Topics: Animals; Cognition Disorders; Eutrophication; Female; Fisheries; Food Contamination; Humans; Kainic Acid; Neuromuscular Depolarizing Agents; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Risk Assessment; Shellfish | 2006 |
Functional restoration using basic fibroblast growth factor (bFGF) infusion in Kainic acid induced cognitive dysfunction in rat: neurobehavioural and neurochemical studies.
Topics: Animals; Antimetabolites; Behavior, Animal; Brain Chemistry; Bromodeoxyuridine; Cell Transplantation; Choline O-Acetyltransferase; Cognition Disorders; Excitatory Amino Acid Agonists; Fibroblast Growth Factor 2; Hippocampus; Image Processing, Computer-Assisted; Immunohistochemistry; Kainic Acid; Male; Maze Learning; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Muscarinic | 2008 |
Basic fibroblast growth factor is highly neuroprotective against seizure-induced long-term behavioural deficits.
Topics: Aging; Animals; Behavior, Animal; Cognition Disorders; Excitatory Amino Acid Agonists; Fibroblast Growth Factor 2; Flurothyl; Handling, Psychological; Kainic Acid; Learning Disabilities; Male; Maze Learning; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Recurrence; Seizures; Status Epilepticus | 1997 |
Progressive neurodegeneration after intracerebroventricular kainic acid administration in rats: implications for schizophrenia?
Topics: Animals; Cerebral Ventricles; Cognition Disorders; Hippocampus; Kainic Acid; Limbic System; Male; Nerve Degeneration; Rats; Schizophrenia; Time Factors | 1998 |
[Beneficial effect and mechanism of 764-3 on cognitive deficit induced by brain damage in rats].
Topics: Animals; Brain Diseases; Ca(2+) Mg(2+)-ATPase; Cognition Disorders; Drugs, Chinese Herbal; Kainic Acid; Male; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase | 1997 |